HHGlim-M2 Tablet PR: A Combination Therapy for Blood Sugar Control

Hhglim-M2 Tablet PR combines the potent antidiabetic agents Glimepiride (2 mg) and Metformin (500 mg) in a convenient, once-daily tablet format. This combination therapy offers synergistic effects to help manage elevated blood glucose levels associated with type 2 diabetes.

Glimepiride: A sulfonylurea medication that stimulates insulin secretion from pancreatic beta cells. It acts directly on these cells to increase glucose uptake and lower blood sugar levels.
Metformin: A biguanide-class drug known for its multifaceted action in controlling blood glucose levels. It improves insulin sensitivity, reduces hepatic glucose production, and slows down glucose absorption in the intestines.

By combining these two powerful agents, Hhglim-M2 provides a comprehensive approach to manage type 2 diabetes effectively. It is crucial for patients under professional medical supervision. Consult with your physician before starting or making changes to any medication regimen.

Please note: This description is intended for informational purposes only and should not be considered as a substitute for professional medical advice or treatment. Always consult with a healthcare provider for diagnosis, treatment, and medication management.